chr2-149576503-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000303319.10(MMADHC):c.412G>A(p.Glu138Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00191 in 1,613,626 control chromosomes in the GnomAD database, including 60 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E138D) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000303319.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMADHC | NM_015702.3 | c.412G>A | p.Glu138Lys | missense_variant | 5/8 | ENST00000303319.10 | NP_056517.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMADHC | ENST00000303319.10 | c.412G>A | p.Glu138Lys | missense_variant | 5/8 | 1 | NM_015702.3 | ENSP00000301920 | P1 | |
MMADHC | ENST00000422782.2 | c.412G>A | p.Glu138Lys | missense_variant | 5/9 | 5 | ENSP00000408331 | |||
MMADHC | ENST00000428879.5 | c.412G>A | p.Glu138Lys | missense_variant | 4/7 | 2 | ENSP00000389060 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00979 AC: 1489AN: 152164Hom.: 30 Cov.: 33
GnomAD3 exomes AF: 0.00259 AC: 651AN: 251334Hom.: 17 AF XY: 0.00196 AC XY: 266AN XY: 135840
GnomAD4 exome AF: 0.00108 AC: 1580AN: 1461344Hom.: 30 Cov.: 33 AF XY: 0.000916 AC XY: 666AN XY: 727006
GnomAD4 genome AF: 0.00982 AC: 1496AN: 152282Hom.: 30 Cov.: 33 AF XY: 0.00947 AC XY: 705AN XY: 74470
ClinVar
Submissions by phenotype
Methylmalonic aciduria and homocystinuria type cblD Benign:3
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Disorders of Intracellular Cobalamin Metabolism Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at